library(arframe)
library(pharmaverseadam)
library(dplyr, warn.conflicts = FALSE)
arm_levels <- c("Placebo", "Xanomeline Low Dose", "Xanomeline High Dose")
chem_params <- c("ALT", "AST", "BILI", "CREAT")
lab_listing <- pharmaverseadam::adlb |>
blank_to_na() |>
filter(
SAFFL == "Y",
TRT01A %in% arm_levels,
PARCAT1 == "CHEMISTRY",
PARAMCD %in% chem_params
) |>
mutate(
TRT01A = factor(TRT01A, levels = arm_levels),
AVAL_C = if_else(is.na(AVAL), NA_character_, sprintf("%.1f", AVAL)),
BASE_C = if_else(is.na(BASE), NA_character_, sprintf("%.1f", BASE)),
CHG_C = if_else(is.na(CHG), NA_character_, sprintf("%.1f", CHG))
) |>
arrange(TRT01A, USUBJID, PARAMCD, AVISITN) |>
slice_head(n = 200) |>
select(
TRT01A,
USUBJID,
PARAM,
AVISIT,
AVAL_C,
BASE_C,
CHG_C,
ANRIND
)Laboratory Test Results Listing
Subject-Level Laboratory Results
Setup
See Prerequisites for installation instructions.
arframe Pipeline
lab_listing |>
fr_table() |>
fr_titles(
"Listing 16.2.8",
"Laboratory Test Results - Chemistry",
"Safety Population"
) |>
fr_cols(
TRT01A = fr_col(visible = FALSE),
USUBJID = fr_col("Subject ID", width = 1.2),
PARAM = fr_col("Parameter", width = 2.4),
AVISIT = fr_col("Visit", width = 1.5),
AVAL_C = fr_col("Result", width = 1.0, align = "decimal"),
BASE_C = fr_col("Baseline", width = 1.0, align = "decimal"),
CHG_C = fr_col("Change from\nBaseline", width = 1.1, align = "decimal"),
ANRIND = fr_col("Normal\nRange Flag", width = 1.0, align = "center")
) |>
fr_header(bold = TRUE, align = "center") |>
fr_rows(page_by = "TRT01A", sort_by = c("USUBJID", "PARAM", "AVISIT"), suppress = c("USUBJID", "PARAM")) |>
fr_footnotes(
"Safety Population: all randomised subjects who received at least one dose of study medication.",
"Parameters: ALT = Alanine Aminotransferase, AST = Aspartate Aminotransferase, BILI = Bilirubin, CREAT = Creatinine.",
"Result and Baseline are in original measurement units. Change from Baseline = Result minus Baseline.",
"Normal Range Flag (ANRIND): HIGH = above upper limit of normal, LOW = below lower limit of normal, NORMAL = within range.",
"First 200 records shown. Sorted by treatment arm, subject identifier, parameter, and visit."
)Rendered Listing
Pages are separated by treatment arm using page_by. Numeric columns use align = "decimal" for alignment on the decimal point. Values are pre-formatted to one decimal place in data preparation.
Listing 16.2.8
Laboratory Test Results - Chemistry
Safety Population
Placebo
| Subject ID | Parameter | Visit | Result | Baseline | Change from Baseline | Normal Range Flag |
|---|---|---|---|---|---|---|
| 01-701-1015 | Alanine Aminotransferase (U/L) | Baseline | 27.0 | 27.0 | NORMAL | |
| POST-BASELINE LAST | 23.0 | 27.0 | -4.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 41.0 | 27.0 | 14.0 | HIGH | ||
| POST-BASELINE MINIMUM | 17.0 | 27.0 | -10.0 | NORMAL | ||
| Week 12 | 27.0 | 27.0 | 0.0 | NORMAL | ||
| Week 16 | 17.0 | 27.0 | -10.0 | NORMAL | ||
| Week 2 | 41.0 | 27.0 | 14.0 | HIGH | ||
| Week 20 | 21.0 | 27.0 | -6.0 | NORMAL | ||
| Week 24 | 23.0 | 27.0 | -4.0 | NORMAL | ||
| Week 26 | 23.0 | 27.0 | -4.0 | NORMAL | ||
| Week 4 | 18.0 | 27.0 | -9.0 | NORMAL | ||
| Week 6 | 26.0 | 27.0 | -1.0 | NORMAL | ||
| Week 8 | 22.0 | 27.0 | -5.0 | NORMAL | ||
| Aspartate Aminotransferase (U/L) | Baseline | 40.0 | 40.0 | HIGH | ||
| POST-BASELINE LAST | 19.0 | 40.0 | -21.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 33.0 | 40.0 | -7.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 19.0 | 40.0 | -21.0 | NORMAL | ||
| Week 12 | 22.0 | 40.0 | -18.0 | NORMAL | ||
| Week 16 | 23.0 | 40.0 | -17.0 | NORMAL | ||
| Week 2 | 33.0 | 40.0 | -7.0 | NORMAL | ||
| Week 20 | 19.0 | 40.0 | -21.0 | NORMAL | ||
| Week 24 | 23.0 | 40.0 | -17.0 | NORMAL | ||
| Week 26 | 19.0 | 40.0 | -21.0 | NORMAL | ||
| Week 4 | 21.0 | 40.0 | -19.0 | NORMAL | ||
| Week 6 | 26.0 | 40.0 | -14.0 | NORMAL | ||
| Week 8 | 21.0 | 40.0 | -19.0 | NORMAL | ||
| Bilirubin (umol/L) | Baseline | 10.3 | 10.3 | NORMAL | ||
| POST-BASELINE LAST | 5.1 | 10.3 | -5.1 | NORMAL | ||
| POST-BASELINE MAXIMUM | 8.5 | 10.3 | -1.7 | NORMAL | ||
| POST-BASELINE MINIMUM | 5.1 | 10.3 | -5.1 | NORMAL | ||
| Week 12 | 6.8 | 10.3 | -3.4 | NORMAL | ||
| Week 16 | 6.8 | 10.3 | -3.4 | NORMAL | ||
| Week 2 | 8.5 | 10.3 | -1.7 | NORMAL | ||
| Week 20 | 6.8 | 10.3 | -3.4 | NORMAL | ||
| Week 24 | 6.8 | 10.3 | -3.4 | NORMAL | ||
| Week 26 | 5.1 | 10.3 | -5.1 | NORMAL | ||
| Week 4 | 6.8 | 10.3 | -3.4 | NORMAL | ||
| Week 6 | 5.1 | 10.3 | -5.1 | NORMAL | ||
| Week 8 | 8.5 | 10.3 | -1.7 | NORMAL | ||
| Creatinine (umol/L) | Baseline | 79.6 | 79.6 | NORMAL | ||
| POST-BASELINE LAST | 88.4 | 79.6 | 8.8 | NORMAL | ||
| POST-BASELINE MAXIMUM | 88.4 | 79.6 | 8.8 | NORMAL | ||
| POST-BASELINE MINIMUM | 70.7 | 79.6 | -8.8 | NORMAL | ||
| Week 12 | 79.6 | 79.6 | 0.0 | NORMAL | ||
| Week 16 | 88.4 | 79.6 | 8.8 | NORMAL | ||
| Week 2 | 88.4 | 79.6 | 8.8 | NORMAL | ||
| Week 20 | 79.6 | 79.6 | 0.0 | NORMAL | ||
| Week 24 | 79.6 | 79.6 | 0.0 | NORMAL | ||
| Week 26 | 88.4 | 79.6 | 8.8 | NORMAL | ||
| Week 4 | 70.7 | 79.6 | -8.8 | NORMAL | ||
| Week 6 | 88.4 | 79.6 | 8.8 | NORMAL | ||
| Week 8 | 88.4 | 79.6 | 8.8 | NORMAL | ||
| 01-701-1023 | Alanine Aminotransferase (U/L) | Baseline | 23.0 | 23.0 | NORMAL | |
| POST-BASELINE LAST | 30.0 | 23.0 | 7.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 30.0 | 23.0 | 7.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 30.0 | 23.0 | 7.0 | NORMAL | ||
| Week 2 | 30.0 | 23.0 | 7.0 | NORMAL | ||
| Week 4 | 38.0 | 23.0 | 15.0 | NORMAL | ||
| Aspartate Aminotransferase (U/L) | Baseline | 21.0 | 21.0 | NORMAL | ||
| POST-BASELINE LAST | 25.0 | 21.0 | 4.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 25.0 | 21.0 | 4.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 25.0 | 21.0 | 4.0 | NORMAL | ||
| Week 2 | 25.0 | 21.0 | 4.0 | NORMAL | ||
| Week 4 | 30.0 | 21.0 | 9.0 | NORMAL | ||
| Bilirubin (umol/L) | Baseline | 12.0 | 12.0 | NORMAL | ||
| POST-BASELINE LAST | 6.8 | 12.0 | -5.1 | NORMAL | ||
| POST-BASELINE MAXIMUM | 6.8 | 12.0 | -5.1 | NORMAL | ||
| POST-BASELINE MINIMUM | 6.8 | 12.0 | -5.1 | NORMAL | ||
| Week 2 | 6.8 | 12.0 | -5.1 | NORMAL | ||
| Week 4 | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Creatinine (umol/L) | Baseline | 123.8 | 123.8 | NORMAL | ||
| POST-BASELINE LAST | 132.6 | 123.8 | 8.8 | NORMAL | ||
| POST-BASELINE MAXIMUM | 132.6 | 123.8 | 8.8 | NORMAL | ||
| POST-BASELINE MINIMUM | 132.6 | 123.8 | 8.8 | NORMAL | ||
| Week 2 | 132.6 | 123.8 | 8.8 | NORMAL | ||
| Week 4 | 114.9 | 123.8 | -8.8 | NORMAL | ||
| 01-701-1047 | Alanine Aminotransferase (U/L) | Baseline | 22.0 | 22.0 | NORMAL | |
| POST-BASELINE LAST | 16.0 | 22.0 | -6.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 16.0 | 22.0 | -6.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 16.0 | 22.0 | -6.0 | NORMAL | ||
| Unscheduled 6.1 | 17.0 | 22.0 | -5.0 | NORMAL | ||
| Week 2 | 16.0 | 22.0 | -6.0 | NORMAL | ||
| Week 4 | 20.0 | 22.0 | -2.0 | NORMAL | ||
| Aspartate Aminotransferase (U/L) | Baseline | 25.0 | 25.0 | NORMAL | ||
| POST-BASELINE LAST | 21.0 | 25.0 | -4.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 21.0 | 25.0 | -4.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 21.0 | 25.0 | -4.0 | NORMAL | ||
| Unscheduled 6.1 | 21.0 | 25.0 | -4.0 | NORMAL | ||
| Week 2 | 21.0 | 25.0 | -4.0 | NORMAL | ||
| Week 4 | 24.0 | 25.0 | -1.0 | NORMAL | ||
| Bilirubin (umol/L) | Baseline | 6.8 | 6.8 | NORMAL | ||
| POST-BASELINE LAST | 8.5 | 6.8 | 1.7 | NORMAL | ||
| POST-BASELINE MAXIMUM | 8.5 | 6.8 | 1.7 | NORMAL | ||
| POST-BASELINE MINIMUM | 8.5 | 6.8 | 1.7 | NORMAL | ||
| Unscheduled 6.1 | 6.8 | 6.8 | 0.0 | NORMAL | ||
| Week 2 | 8.5 | 6.8 | 1.7 | NORMAL | ||
| Week 4 | 6.8 | 6.8 | 0.0 | NORMAL | ||
| Creatinine (umol/L) | Baseline | 88.4 | 88.4 | NORMAL | ||
| POST-BASELINE LAST | 88.4 | 88.4 | 0.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 88.4 | 88.4 | 0.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 88.4 | 88.4 | 0.0 | NORMAL | ||
| Unscheduled 6.1 | 88.4 | 88.4 | 0.0 | NORMAL | ||
| Week 2 | 88.4 | 88.4 | 0.0 | NORMAL | ||
| Week 4 | 79.6 | 88.4 | -8.8 | NORMAL | ||
| 01-701-1118 | Alanine Aminotransferase (U/L) | Baseline | 15.0 | 15.0 | NORMAL | |
| POST-BASELINE LAST | 10.0 | 15.0 | -5.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 16.0 | 15.0 | 1.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 7.0 | 15.0 | -8.0 | NORMAL | ||
| Week 12 | 16.0 | 15.0 | 1.0 | NORMAL | ||
| Week 16 | 15.0 | 15.0 | 0.0 | NORMAL | ||
| Week 2 | 7.0 | 15.0 | -8.0 | NORMAL | ||
| Week 20 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 24 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 26 | 10.0 | 15.0 | -5.0 | NORMAL | ||
| Week 4 | 15.0 | 15.0 | 0.0 | NORMAL | ||
| Week 6 | 11.0 | 15.0 | -4.0 | NORMAL | ||
| Week 8 | 15.0 | 15.0 | 0.0 | NORMAL | ||
| Aspartate Aminotransferase (U/L) | Baseline | 15.0 | 15.0 | NORMAL | ||
| POST-BASELINE LAST | 12.0 | 15.0 | -3.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 18.0 | 15.0 | 3.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 11.0 | 15.0 | -4.0 | NORMAL | ||
| Week 12 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 16 | 18.0 | 15.0 | 3.0 | NORMAL | ||
| Week 2 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 20 | 14.0 | 15.0 | -1.0 | NORMAL | ||
| Week 24 | 11.0 | 15.0 | -4.0 | NORMAL | ||
| Week 26 | 12.0 | 15.0 | -3.0 | NORMAL | ||
| Week 4 | 14.0 | 15.0 | -1.0 | NORMAL | ||
| Week 6 | 15.0 | 15.0 | 0.0 | NORMAL | ||
| Week 8 | 18.0 | 15.0 | 3.0 | NORMAL | ||
| Bilirubin (umol/L) | Baseline | 12.0 | 12.0 | NORMAL | ||
| POST-BASELINE LAST | 8.5 | 12.0 | -3.4 | NORMAL | ||
| POST-BASELINE MAXIMUM | 10.3 | 12.0 | -1.7 | NORMAL | ||
| POST-BASELINE MINIMUM | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Week 12 | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Week 16 | 10.3 | 12.0 | -1.7 | NORMAL | ||
| Week 2 | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Week 20 | 10.3 | 12.0 | -1.7 | NORMAL | ||
| Week 24 | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Week 26 | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Week 4 | 10.3 | 12.0 | -1.7 | NORMAL | ||
| Week 6 | 8.5 | 12.0 | -3.4 | NORMAL | ||
| Week 8 | 10.3 | 12.0 | -1.7 | NORMAL | ||
| Creatinine (umol/L) | Baseline | 88.4 | 88.4 | NORMAL | ||
| POST-BASELINE LAST | 97.2 | 88.4 | 8.8 | NORMAL | ||
| POST-BASELINE MAXIMUM | 106.1 | 88.4 | 17.7 | NORMAL | ||
| POST-BASELINE MINIMUM | 88.4 | 88.4 | 0.0 | NORMAL | ||
| Week 12 | 106.1 | 88.4 | 17.7 | NORMAL | ||
| Week 16 | 97.2 | 88.4 | 8.8 | NORMAL | ||
| Week 2 | 88.4 | 88.4 | 0.0 | NORMAL | ||
| Week 20 | 106.1 | 88.4 | 17.7 | NORMAL | ||
| Week 24 | 97.2 | 88.4 | 8.8 | NORMAL | ||
| Week 26 | 97.2 | 88.4 | 8.8 | NORMAL | ||
| Week 4 | 106.1 | 88.4 | 17.7 | NORMAL | ||
| Week 6 | 97.2 | 88.4 | 8.8 | NORMAL | ||
| Week 8 | 88.4 | 88.4 | 0.0 | NORMAL | ||
| 01-701-1130 | Alanine Aminotransferase (U/L) | Baseline | 15.0 | 15.0 | NORMAL | |
| POST-BASELINE LAST | 10.0 | 15.0 | -5.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 18.0 | 15.0 | 3.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 10.0 | 15.0 | -5.0 | NORMAL | ||
| Week 12 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 16 | 12.0 | 15.0 | -3.0 | NORMAL | ||
| Week 2 | 14.0 | 15.0 | -1.0 | NORMAL | ||
| Week 20 | 11.0 | 15.0 | -4.0 | NORMAL | ||
| Week 24 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 26 | 10.0 | 15.0 | -5.0 | NORMAL | ||
| Week 4 | 18.0 | 15.0 | 3.0 | NORMAL | ||
| Week 6 | 13.0 | 15.0 | -2.0 | NORMAL | ||
| Week 8 | 10.0 | 15.0 | -5.0 | NORMAL | ||
| Aspartate Aminotransferase (U/L) | Baseline | 24.0 | 24.0 | NORMAL | ||
| POST-BASELINE LAST | 19.0 | 24.0 | -5.0 | NORMAL | ||
| POST-BASELINE MAXIMUM | 26.0 | 24.0 | 2.0 | NORMAL | ||
| POST-BASELINE MINIMUM | 18.0 | 24.0 | -6.0 | NORMAL | ||
| Week 12 | 21.0 | 24.0 | -3.0 | NORMAL | ||
| Week 16 | 19.0 | 24.0 | -5.0 | NORMAL | ||
| Week 2 | 26.0 | 24.0 | 2.0 | NORMAL | ||
| Week 20 | 19.0 | 24.0 | -5.0 | NORMAL | ||
| Week 24 | 22.0 | 24.0 | -2.0 | NORMAL | ||
| Week 26 | 19.0 | 24.0 | -5.0 | NORMAL | ||
| Week 4 | 25.0 | 24.0 | 1.0 | NORMAL | ||
| Week 6 | 19.0 | 24.0 | -5.0 | NORMAL | ||
| Week 8 | 18.0 | 24.0 | -6.0 | NORMAL | ||
| Bilirubin (umol/L) | Baseline | 8.5 | 8.5 | NORMAL | ||
| POST-BASELINE LAST | 10.3 | 8.5 | 1.7 | NORMAL | ||
| POST-BASELINE MAXIMUM | 12.0 | 8.5 | 3.4 | NORMAL | ||
| POST-BASELINE MINIMUM | 5.1 | 8.5 | -3.4 | NORMAL | ||
| Week 12 | 8.5 | 8.5 | 0.0 | NORMAL | ||
| Week 16 | 10.3 | 8.5 | 1.7 | NORMAL | ||
| Week 2 | 10.3 | 8.5 | 1.7 | NORMAL | ||
| Week 20 | 6.8 | 8.5 | -1.7 | NORMAL | ||
| Week 24 | 12.0 | 8.5 | 3.4 | NORMAL | ||
| Week 26 | 10.3 | 8.5 | 1.7 | NORMAL | ||
| Week 4 | 5.1 | 8.5 | -3.4 | NORMAL | ||
| Week 6 | 6.8 | 8.5 | -1.7 | NORMAL | ||
| Week 8 | 10.3 | 8.5 | 1.7 | NORMAL | ||
| Creatinine (umol/L) | Baseline | 123.8 | 123.8 | NORMAL | ||
| Week 2 | 123.8 | 123.8 | 0.0 | NORMAL | ||
| Week 4 | 176.8 | 123.8 | 53.0 | HIGH | ||
| Week 6 | 123.8 | 123.8 | 0.0 | NORMAL | ||
| Week 8 | 114.9 | 123.8 | -8.8 | NORMAL |
Safety Population: all randomised subjects who received at least one dose of study medication.
Parameters: ALT = Alanine Aminotransferase, AST = Aspartate Aminotransferase, BILI = Bilirubin, CREAT = Creatinine.
Result and Baseline are in original measurement units. Change from Baseline = Result minus Baseline.
Normal Range Flag (ANRIND): HIGH = above upper limit of normal, LOW = below lower limit of normal, NORMAL = within range.
First 200 records shown. Sorted by treatment arm, subject identifier, parameter, and visit.
/opt/quarto/share/rmd/rmd.R
01APR2026 09:50:59